Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)

NCT01869881 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Anplag(Sarpogrelate)
DRUG: Placebo

Sponsor

Yuhan Corporation